Browsing: Business News

Toronto biotech Biossil raised US$153 million at a US$1-billion valuation in an OpenAI-led round announced Sept. 28, making it Canada’s newest unicorn. The company uses AI to find new uses for drug candidates that failed in clinical trials, BetaKit reported.